Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different aspirin doses for prevention of preeclampsia
ChiCTR1800017524Phase 4Recruiting
- Sponsor
- International Peace Maternity and Child Health Hospital
- Start
- Apr 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aspirin in preeclampsia (4 arms), sponsored by International Peace Maternity and Child Health Hospital. Primary endpoints: Uterine artery resistance, Coagulation index and 1 more. Started Apr 2016; status: recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on ChiCTR1800017524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017524.